Basaglar Cartridges

Composition of Basaglar Cartridges

Basaglar Cartridges contains Insulin glargine 100 IU/mL (3 mL cartridge contains 300 IU). It belongs to the Long-acting insulin analogue (Basal insulin) class of medicines.

Uses of Basaglar Cartridges

Treatment of diabetes mellitus to improve glycaemic control: type 1 diabetes (as basal insulin with mealtime insulin) and type 2 diabetes (alone or with other antidiabetic medicines)

Key benefits

• Provides 24-hour basal glucose control
• Helps reduce fasting blood sugar
• Once-daily dosing convenience
• Supports HbA1c reduction when used appropriately
• Suitable basal insulin option in type 1 and type 2 diabetes

How Basaglar Cartridges works

Insulin glargine is a long-acting basal insulin analogue. After subcutaneous injection it forms microprecipitates that release insulin slowly and steadily over ~24 hours, lowering blood glucose by increasing peripheral glucose uptake and reducing hepatic glucose production.

How to take Basaglar Cartridges

For subcutaneous injection only using a compatible insulin pen for cartridges. Inject once daily at the same time each day into abdomen, thigh, or upper arm; rotate injection sites. Do not dilute or mix with other insulins in the same syringe. Dose is individualised based on blood glucose; follow physician advice. Not for IV use or insulin pump.

Take it exactly as your doctor prescribed. Do not change the dose or stop early on your own.

Missed dose and overdose

If you miss a dose

Take the missed dose of Basaglar Cartridges as soon as you remember. If it is almost time for the next dose, skip the missed one and carry on with the usual schedule. Do not take two doses together to make up for a missed dose.

If you take too much

Taking more Basaglar Cartridges than prescribed can be harmful. If you suspect an overdose, contact a doctor or go to the nearest emergency department at once, and carry the pack or strip with you. In India the emergency number is 112.

Side effects of Basaglar Cartridges

Most side effects of Basaglar Cartridges are mild and settle as the body adjusts. Reported side effects include:

• Hypoglycaemia
• injection site reactions (pain/redness/swelling/itching)
• lipodystrophy
• weight gain
• oedema
• rash
• allergic reactions

Stop the medicine and seek help immediately for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.

Safety advice for Basaglar Cartridges

Warnings and precautions

Risk of hypoglycaemia (especially with missed meals, increased activity, dose errors); monitor blood glucose regularly. Do not use during episodes of hypoglycaemia. Use caution in renal/hepatic impairment, elderly, and when switching from other insulins (dose adjustment may be needed). Rotate injection sites to reduce lipodystrophy. Seek urgent care for severe allergy, breathing difficulty, or severe hypoglycaemia. Ensure correct insulin and strength (U-100) to avoid dosing errors.

Interactions with other medicines

Other antidiabetics (additive hypoglycaemia), corticosteroids (increase glucose), thiazide diuretics (increase glucose), thyroid hormones (increase glucose), sympathomimetics (increase glucose), beta-blockers (may mask hypoglycaemia symptoms), ACE inhibitors/ARBs (may increase hypoglycaemia), salicylates (may increase hypoglycaemia), alcohol (may increase risk of hypoglycaemia), pioglitazone (risk of fluid retention/heart failure when combined with insulin)

How to store Basaglar Cartridges

Unopened cartridges: store refrigerated at 2–8°C, do not freeze; keep in original carton to protect from light. In-use cartridge/pen: keep at room temperature (generally below 25–30°C as per label), away from heat and direct light; do not refrigerate if label advises; discard after the in-use period stated on pack (commonly 28 days) or if exposed to extreme temperatures.

Manufacturer and class

Manufacturer:

CIPLA LIMITED

Therapeutic class:

Antidiabetic

Drug class:

Long-acting insulin analogue (Basal insulin)